Atopic dermatitis Trials in Mayfield Heights, United States
Conditions / Atopic dermatitis / Mayfield Heights, United States
Atopic dermatitis is a medical condition with active clinical research programs worldwide.
12 total trials for this combination
Showing top 10 of 12 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT05995964 | A Study To Learn About Two Study Medicines (PF-07275315 And PF-07264660) In People Who Have Moderate To Severe Atopic Dermatitis | RECRUITING | PHASE2 |
| NCT05399368 | An Efficacy and Safety Study of RPT193 in Adults With Atopic Dermatitis | TERMINATED | PHASE2 |
| NCT07037901 | A Study to Evaluate the Efficacy and Safety of IMG-007 in Adult Participants With Moderate-to-Severe Atopic Dermatitis | RECRUITING | PHASE2 |
| NCT05032859 | Tapinarof for the Treatment of Atopic Dermatitis in Children and Adults (DMVT-505-3102) | COMPLETED | PHASE3 |
| NCT05882877 | A Study to Assess Long-term Safety, Tolerability, and Efficacy of Rocatinlimab in Adult and Adolescent Participants With Moderate-to-severe Atopic Dermatitis (AD) | ACTIVE_NOT_RECRUITING | PHASE3 |
| NCT05923099 | A Trial to Evaluate the Efficacy and Safety of Different Doses of LEO 138559 in Adults With Moderate-to-severe Atopic Dermatitis | COMPLETED | PHASE2 |
| NCT05469464 | Study to Assess the Efficacy and Safety of Orismilast in Atopic Dermatitis (ADESOS) | COMPLETED | PHASE2 |
| NCT05704738 | A Study to Evaluate Rocatinlimab (AMG 451) in Adolescent Participants With Moderate-to-severe Atopic Dermatitis (AD) | COMPLETED | PHASE3 |
| NCT05899816 | A Study Assessing Rocatinlimab on Vaccine Antibody Response in Moderate-to-severe Atopic Dermatitis (AD) (ROCKET - VOYAGER) | COMPLETED | PHASE3 |
| NCT05142774 | Long Term Extension Study of Tapinarof Cream, 1% for Subjects With Atopic Dermatitis | COMPLETED | PHASE3 |